Veterinary Vaccines Market to Reach $11.13 Billion by 2030
o
Veterinary
Vaccines Market to Reach $11.13
Billion by
2030
|
Meticulous Research®—a leading global
market research company, published a research report titled, ‘Veterinary Vaccines Market by Type (Live,
Inactive, Recombinant) Animal (Livestock [Ruminant, Poultry, Pig], Companion
[Dog, Cat]) Administration Route (Oral, Parenteral, Nasal) Distribution
Channel (Hospital & Clinic, Pharmacy) - Global Forecast to 2030’.
Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5618
According to this latest publication from
Meticulous Research®, the veterinary vaccines market is expected to grow at a CAGR of
6.1% from 2023 to reach $11.13 billion by 2030. The growth of this market is
driven by the increasing livestock population, growing pet adoption,
increasing prevalence of diseases in animals, and growing demand for
animal-derived food products. However, the high cost of manufacturing and
vaccine storage restrain the growth of this market. Additionally, increasing
awareness regarding animal health and growing expenditure on animal health and
pet insurance are expected to create growth opportunities for the stakeholders
in this market. However, low awareness regarding animal health in developing
countries is a major challenge to market growth.
Key Players
The key players operating in the veterinary
vaccines market are Zoetis Inc. (U.S.), Virbac (France), Ceva Santé
Animale (France), Boehringer Ingelheim International GmbH (Germany),
Phibro Animal Health Corporation (U.S.), Merck & Co., Inc (U.S.), Elanco
Animal Health Inc. (U.S.), Vetoquinol (France), Neogen Corporation (U.S.), and
Indian Immunologicals Ltd. (India).
Veterinary Vaccines Market:
Future Outlook
The global veterinary vaccines market is
segmented by type (live attenuated vaccines, inactive vaccines, recombinant
vaccines, and other vaccines), animal type (livestock [ruminants, poultry,
porcine, and other livestock], companion animals [canine, feline, and other
companion animals]), route of administration (oral, intranasal, and
parenteral), distribution channels (veterinary hospitals & clinics,
pharmacies, and mobile veterinary units), and geography. The study also
evaluates industry competitors and analyzes the market at the regional and
country levels.
Based on type, the veterinary
vaccines market is segmented into live attenuated vaccines, inactive vaccines,
recombinant vaccines, and other vaccines. In 2023, the live attenuated vaccines
segment is expected to account for the largest share of the market. This large
share can be attributed to the high effectiveness of live attenuated vaccines.
Live attenuated vaccines are the most traditional type of vaccines used. When
introduced into the body, these vaccines initiate an immune repose against
pathogens, helping the immune system fight the infection in the future.
Based on animal type, the veterinary
vaccines market is segmented into livestock and companion animals. The
livestock segment is expected to grow at a higher CAGR during the forecast
period. Factors contributing to the segment’s growth are increasing demand and
consumption of animal-derived food products in developing countries,
increasing livestock population to meet the growing demand, and government
initiatives to prevent and reduce animal disease occurrence. The governments
of several countries are undertaking various initiatives to prevent animal
diseases. For instance, in 2023, the Government of India launched two
initiatives Animal Pandemic Preparedness Initiatives and World Bank-funded
Animal Health System Support for One Health, under these initiatives. These
initiatives aim to strengthen integrated disease surveillance &
monitoring, early warning & response, vaccine/ diagnostics, R&D, and
production for animal diseases in the country.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5618
Based on administration
route, the veterinary vaccines market is segmented into parenteral,
oral, and intranasal. In 2023, the parenteral segment is expected to account
for the larger share of the market. This large share is attributed to the
animals’, especially pets’, reluctance towards oral vaccines and easy and high
vaccine absorption through the intramuscular route.
Based on distribution
channel, the veterinary vaccines market is segmented into veterinary
hospitals & clinics, pharmacies, and mobile veterinary units. The
veterinary hospitals & clinics segment is estimated to account for the
largest share of the veterinary vaccines market in 2023. The large share of
this segment is attributed to the animal owners' high preference for hospitals
& clinics, easy accessibility, and the growing burden of diseases in
animals. As licensed professionals should administer the vaccines, pet owners
and farmers prefer hospitals and clinics for routine vaccine appointments
leading to a large share of the segment.
Geographic Review
This research report analyzes major
geographies and provides a comprehensive analysis of the veterinary vaccines
market in North America (U.S. and Canada), Europe (Germany, France, U.K.,
Italy, Spain, and RoE), Asia-Pacific (Japan, China, India, and RoAPAC), Latin
America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa. North
America is expected to dominate the veterinary vaccines market in 2023,
followed by Europe and Asia-Pacific. Well-established agriculture and animal
husbandry, awareness of animal health among farmers and pet owners, high
production and export of animal-derived food products, and a large pet
population base are expected to support North America’s large share.
Quick Buy: https://www.meticulousresearch.com/Checkout/47677660
Key Questions Answered in
the Report-
· What is
the current revenue generated through the sale of veterinary vaccines across
the globe?
· At what
rate is the demand for veterinary vaccines projected to grow over the next 5–7
years?
· What is
the historical market size and growth rate of the global veterinary vaccines
market?
· What are
the major factors impacting the growth of this market at the global and
regional levels? What are the major opportunities for existing market players
and new entrants in the market?
· Which
segments in terms of type, animal type, route of administration, and
distribution channels are creating major traction for the vendors in this
market?
· What are
the key geographical trends in this market? Which regions/countries are
expected to offer significant growth opportunities for the vendors operating
in the global veterinary vaccines market?
· Who are
the major players in the global veterinary vaccines market? And what are their
specific vaccine offerings in the veterinary vaccines market?
· What are
the recent strategic developments in the global veterinary vaccines market,
and what are the impacts of these developments on the global market?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment